Peptides, Pseudomonas aeruginosa, polysaccharides and lipopolysaccharides - Players in the predicament of cystic fibrosis patients

Trends in Microbiology

Volumn 8, Issue 6, 2000, Pages 247-250

  Pier, Gerald B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; CYCLIC AMP; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 8; LIPID A; LIPOPOLYSACCHARIDE;

ACYLATION; ADAPTATION; ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; CHRONIC LUNG DISEASE; CYSTIC FIBROSIS; CYTOKINE RELEASE; ENDOTHELIUM CELL; GAS CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; LIPID ANALYSIS; LUNG INFECTION; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE;

PSEUDOMONAS AERUGINOSA;

EID: 0034212290     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(00)01743-1     Document Type: Short Survey

References (26)

1. J.R Govan V Deretic Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia Microbiol. Rev. 60 1996 539 574
2. V Deretic Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors J. Bacteriol. 176 1994 2773 2780
3. S Roychoudhury Pseudomonas aeruginosa infection in cystic fibrosis – biosynthesis of alginate as a virulence factor J.Y Homma Pseudomonas aeruginosa in Human Diseases 1991 S. Karger AG 63 67
4. J Lam Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis Infect. Immun. 28 1980 546 556
5. G.J Meluleni Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients J. Immunol. 155 1995 2029 2038
6. R.E.W Hancock Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, non-typable strains deficient in lipopolysaccharide O side chains Infect. Immun. 42 1983 170 177
7. G.B Pier P Ames Mediation of the killing of rough, mucoid isolates of Pseudomonas aeruginosa from patients with cystic fibrosis by the alternative pathway of complement J. Infect. Dis. 150 1984 223 228
8. R.K Ernst Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa Science 286 1999 1561 1565
9. R Bhat Structural studies of lipid A from Pseudomonas aeruginosa PAO1 – occurrence of 4-amino-4-deoxyarabinose J. Bacteriol. 172 1990 6631 6636
10. D.N Karunaratne Characterization of lipid A from Pseudomonas aeruginosa O-antigenic B-band lipopolysaccharide by 1D and 2D NMR and mass spectral analysis Arch. Biochem. Biophys. 299 1992 368 376
11. S.G Wilkinson L Galbraith Studies of lipopolysaccharides from Pseudomonas aeruginosa Eur. J. Biochem. 52 1975 331 343
12. G.B Pier Correlation of the biological response of C3H/HeJ mice to endotoxin with the chemical and structural properties of the lipopolysaccharides from Pseudomonas aeruginosa and Escherichia coli J. Immunol. 127 1981 184 191
13. D.T Drewry Studies of lipid A fractions from the lipopolysaccharides of Pseudomonas aeruginosa and Pseudomonas alcaligenes Biochem. J. 133 1973 563 569
14. R.S Conrad C Galanos Fatty acid alterations and polymyxin-B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin-B resistance Antimicrob. Agents Chemother. 33 1989 1724 1728
15. A Kharazmi Relationship between chemical composition and biological function of Pseudomonas aeruginosa lipopolysaccharide – effect on human neutrophil chemotaxis and oxidative burst J. Leukocyte Biol. 49 1991 15 20
16. R.S Conrad H.E Gilleland Jr. Lipid alterations in cell envelopes of polymyxin-resistant Pseudomonas aeruginosa isolates J. Bacteriol. 148 1981 487 497
17. E.L MacFarlane phoP—phoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance Mol. Microbiol. 34 1999 305 316
18. J.J Smith Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid Cell 85 1996 229 236
19. M.R Knowles Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects J. Clin. Invest. 100 1997 2588 2595
20. S.M Travis Activity of abundant antimicrobials of the human airway Am. J. Respir. Cell. Mol. Biol. 20 1999 872 879
21. P.K Singh Production of beta-defensins by human airway epithelia Proc. Natl. Acad. Sci. U. S. A. 95 1998 14 961—14 966
22. M.J Goldman Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis Cell 88 1997 553 560
23. Cystic Fibrosis Foundation. Patient registry 1998 annual data report, Bethesda, MD, USA.
24. C.A Demko Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection J. Clin. Epidemiol. 48 1995 1041 1049
25. K McCaffery Systematic review of anti-staphylococcal antibiotic therapy in cystic fibrosis Thorax 54 1999 380 383
26. J Lagace Circulating immune complexes, antibodies to Pseudomonas aeruginosa and pulmonary status in cystic fibrosis J. Clin. Lab. Immunol. 30 1989 7 11